UNILATERAL TRANSIENT VISION LOSS FOLLOWING BILATERAL INTRAVITREAL OCRIPLASMIN – CASE REPORT WITH TWO YEARS FOLLOW UP
Abstract Background: Ocriplasmin is a serine protease approved for the treatment of symptomatic vitreomacular traction (VMT). Post-marketing experience has revealed safety concerns. Materials and Methods: Retrospective case report. Clinical and surgical data were analyzed. Results: We report a case...
Main Author: | |
---|---|
Other Authors: | , , |
Format: | report |
Language: | eng |
Published: |
2020
|
Subjects: | |
Online Access: | https://doi.org/10.48560/rspo.20166 |
Country: | Portugal |
Oai: | oai:ojs.revistas.rcaap.pt:article/20166 |